Nevada lawmakers are trying to address everything from marijuana users’ gun rights to the danger that edible marijuana products pose to children.
Source: 6 marijuana bills in Nevada that could change guns rights, edibles, pot research
A state-run survey of 37,000 middle and high school students in Washington state finds that marijuana legalization there has had no effect on youngsters’ propensity to use the drug.
Source: A big thing marijuana opponents warned you about is definitely not happening – The Washington Post
A News Release was issued by the OLCC Sunday Night:
March 18, 2017
Oregon Liquor Control Commission Issues Marijuana Recall:
Portland, Oregon – The Oregon Liquor Control Commission is issuing an immediate health and safety advisory due to the identification of potentially unsafe pesticide residue on retail plant material produced from marijuana cultivated by Emerald Wave Estate, LLC.
The affected marijuana failed a pesticide test for pyrethrins exceeding the Oregon Health Authority action level for this class of pesticide.
Affected products include marijuana flower; the retailer that sold the product has issued a voluntary recall. The marijuana flower was sold at Buds 4 U LLC located at 10692 Highway 126, Suite 4, Mapleton, Oregon.
A wholesaler transferred the product to the retailer before the pesticide results were recorded in the OLCC Cannabis Tracking System (CTS). Buds 4 U sold 82.5 grams to 31 customers between March 8 and March 10, 2017. The retailer noticed the failed pesticide results in the CTS on March 10, 2017 and immediately contacted the OLCC.
The affected marijuana should bear a label that includes one of the following OLCC License numbers:
050-1002850B56E
060-100301304FE
050-1002850B56E
and any of the following package numbers:
1A4010300005B05000000772 – product name: Blue Magoo
1A4010300005B05000000769 – product name: Blue Magoo
1A4010300005911000000005 – product name: Blue Magoo
The remainder of the affected nine pound batch of marijuana flower has been placed on administrative hold, meaning it cannot be lawfully transferred, pending the outcome of an additional pesticide retest. Consumers who have these recalled products should dispose of the products or return them to the retailer where they were purchased.
There have been no reports of illness. The possible health impact of consuming marijuana products with unapproved pesticide residues is unknown. Short and long-term health impacts may exist depending on the specific product, duration, frequency, level of exposure, and route of exposure. Consumers with concerns about their personal health should contact their physician with related questions.
Consumers with questions or concerns about recalled product or pesticide residues in marijuana products are encouraged to contact the product retailer and/or the Oregon Poison Center at 800-222-1222.
For More Information: www.marijuana.oregon.gov
Email: marijuana@oregon.gov
Phone: 503-872-5000 Toll Free: 800-452-6522
Source: Oregon Issues Another Marijuana Recall for Pesticides – Oregon Cannabis Connection
H.R. 975 would provide significant clarity when it comes to providing basic banking services to the cannabis industry.
On March 16, 2017 Arizona Court of Appeals judge, Samuel Thumma, rejected arguments by the Arizona Cannabis Nurses Association that it was illegal for Will Humble, then the director of the agency, to conclude that the only legitimate use of marijuana for PTSD is for “palliative care,” meaning helping to alleviate the symptoms. The Appeals Court upholds Arizona state limits on marijuana for PTSD.
In 2014, then Medical Director, William Humble, added PTST as a qualifying condition to the 2010 voter-approved Arizona Medical Marijuana Act. This happened after multiple years of claiming there was no evidence to support marijuanas value in treating PTSD. While he added the condition, it came with restrictions including:
“doctors could recommend marijuana only to patients who already were being treated for PTSD, even if it was only counseling sessions. Humble said he wanted to be sure that physicians were not promoting marijuana as the first course of action before trying something else.”
The Arizona Cannabis Nurses Association sued, contending Humble had no right to impose such restrictions. However, the Judge said challengers had not shown that Humble had exceeded his legal authority in setting the restrictions.
Source: Appeals Court upholds state limits on marijuana for PTSD | The Daily Courier | Prescott, AZ
Since Pennsylvania is not a referendum state, meaning voters cannot get a question regarding the law placed on the ballot, it will be up to the legislature to take the lead if recreational marijuana is to be legalized.
Gov. Tom Wolf believes “We just aren’t ready yet.” However, recently Auditor General Eugene Depasquale of PA described he has observed support to be “overwhelmingly positive” and that regulating and taxing marijuana could make a dent in Pa’s $3 billion budget deficit. He also described the likelihood of PA legislatures moving towards recreational cannabis any time soon:
“The Pennsylvania Legislature is not known for its dynamic speed,” he said, “except, of course, when they passed the middle-of-the-night pay raise. That moved pretty quickly.”
Source: Depasquale: Pa. voters high on legalized pot proposal
The Detroit News reports that new figures released this week by the city reveal that only two prospective Medical Marijuana Caregiver Centers out of more than 260 applicants have been approved to operate.
The new rules allow Detroit to shut down marijuana shops failing to seek compliance under the ordinance or dispensing medical marijuana in unapproved zones. So far, 136 shops have closed down.
Source: Fox47news.com
Chronic pain sufferers will now be able to get medical marijuana prescribed to them in New York.
Source: Medical marijuana for chronic pain starts next week
After announcing in December it planned to add chronic pain to its list of eligible conditions, the state Health Department on Thursday said medical marijuana for the ailment will be available starting 3/22/17.
Read more about New York’s Seed to Sale Program here or checkout more Data regarding Marijuana in New York here.
“Lawmakers appear to have reached a compromise Thursday that would expand Georgia’s medical marijuana law.
The agreement over Senate Bill 16would add six illnesses and conditions eligible for treatment with medical marijuana in Georgia to include Alzheimer’s disease, AIDS, autism, epidermolysis bullosa, peripheral neuropathy and Tourette’s syndrome. It would additionally allow use for patients in hospice care, according to both state Sen. Ben Watson, R-Savannah, and state Rep. Allen Peake, R-Macon.
It would also keep the maximum allowable THC percentage in the form of cannabis oil allowed here at 5 percent.”
Source: AJC.Com
Across Pennsylvania would-be medical marijuana companies are out pounding the pavement, trying to lock down locations and approvals in the hopes that they may be granted one of the state’s few coveted operating permits. Businesses seek to stake claims in Pa. medical marijuana gold rush
Source: Businesses seek to stake claims in Pa. medical marijuana gold rush | PennLive.com
Pennsylvania will accept applications from prospective growers/processors and dispensaries until March 20.
Do you need help with writing or preparing an application for a marijuana dispensary, cultivation or production facility? We’ve got you covered. Our group of cannabis and application writing specialists have won many licenses in multiple states!
We are familiar with the PA application, have plenty of content prepared for business plans and would be happy to help with the finishing touches on your application!
If you need a consult on the applications, Contact Us!
